Analyzing...
Loading company...
Intelligence analysis not yet available for this company.
No significant concerns identified
Nothing flagged for monitoring
Historical valuation data not available.
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
| (₹ Cr) | TTM | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|---|---|---|
| Other Income | ₹209 Cr +4.2% | ₹200 Cr 0.0% | ₹200 Cr +88.4% | ₹106 Cr 0.0% | ₹106 Cr +17.7% | ₹90 Cr 0.0% | ₹90 Cr +15.6% | ₹78 Cr |
| Total Income | ₹24,424 Cr +11.0% | ₹21,994 Cr 0.0% | ₹21,994 Cr +14.8% | ₹19,166 Cr 0.0% | ₹19,166 Cr +14.7% | ₹16,703 Cr 0.0% | ₹16,703 Cr +13.3% | ₹14,741 Cr |
| COGS | ₹12,602 Cr +11.4% | ₹11,310 Cr 0.0% | ₹11,310 Cr +15.3% | ₹9,806 Cr 0.0% | ₹9,806 Cr +14.4% | ₹8,574 Cr 0.0% | ₹8,574 Cr +13.2% | ₹7,573 Cr |
| ₹21,995 Cr +10.0% | ₹19,988 Cr 0.0% | ₹19,988 Cr +12.3% | ₹17,805 Cr 0.0% | ₹17,805 Cr +14.4% | ₹15,559 Cr 0.0% | ₹15,559 Cr +15.6% | ₹13,457 Cr | |
| Profit Before Tax | ₹2,410 Cr +20.1% | ₹2,006 Cr 0.0% | ₹2,006 Cr +47.2% | ₹1,363 Cr 0.0% | ₹1,363 Cr +19.1% | ₹1,144 Cr 0.0% | ₹1,144 Cr -27.5% | ₹1,578 Cr |
| Exceptional Items | (₹19 Cr) | ₹0.00 Cr | ₹0.00 Cr -100.0% | ₹2 Cr 0.0% | ₹2 Cr | ₹0.00 Cr | ₹0.00 Cr -100.0% | ₹294 Cr |
| ₹589 Cr +10.3% | ₹534 Cr 0.0% | ₹534 Cr +19.9% | ₹446 Cr 0.0% | ₹446 Cr +73.9% | ₹256 Cr 0.0% | ₹256 Cr -46.3% | ₹477 Cr | |
| Net Profit | ₹1,866 Cr +24.0% | ₹1,505 Cr 0.0% | ₹1,505 Cr +61.0% | ₹935 Cr 0.0% | ₹935 Cr +10.7% | ₹845 Cr 0.0% | ₹845 Cr -23.8% | ₹1,108 Cr |
| Profit (Owners) | ₹1,802 Cr +24.6% | ₹1,446 Cr 0.0% | ₹1,446 Cr +60.9% | ₹899 Cr 0.0% | ₹899 Cr +9.7% | ₹819 Cr 0.0% | ₹819 Cr -22.4% | ₹1,056 Cr |
| Minority Interest | ₹64 Cr +7.9% | ₹59 Cr 0.0% | ₹59 Cr +62.6% | ₹36 Cr 0.0% | ₹36 Cr +42.7% | ₹26 Cr 0.0% | ₹26 Cr -51.7% | ₹53 Cr |
| Other Comprehensive Income | ₹60 Cr ↑ Recovery | (₹6 Cr) 0.0% | (₹6 Cr) +39.4% | (₹10 Cr) 0.0% | (₹10 Cr) +21.6% | (₹13 Cr) 0.0% | (₹13 Cr) -36.5% | (₹10 Cr) |
| EPS | ₹125.32 | ₹100.56 | ₹100.56 | ₹62.50 | ₹62.50 | ₹56.97 | ₹56.97 | ₹73.42 |
| Diluted Shares | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
| Profit Or Loss Of Associates | ₹45 Cr +37.3% | ₹33 Cr 0.0% | ₹33 Cr +83.3% | ₹18 Cr 0.0% | ₹18 Cr ↑ Recovery | (₹43 Cr) 0.0% | (₹43 Cr) ↓ Decline | ₹7 Cr |
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Transcript
Apollo Hospitals Enterprise Limited has informed the Exchange about Link of Recording
Apollo Hospitals Enterprise Limited has informed the Exchange about Investor Presentation
Apollo Hospitals Enterprise Limited has informed the Exchange about Investor Presentation
Apollo Hospitals Enterprise Limited has informed the Exchange about Presentation
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Apollo Hospitals announces Q3FY26 resultsStrong growth in Revenue and EBITDA ac...
Apollo Hospitals Enterprise Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 16-Feb-2026.
Apollo Hospitals Enterprise Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Apollo Hospitals Enterprise Limited has informed the Exchange about Schedule of meet
Apollo Hospitals Enterprise Limited has informed the Exchange about Credit Rating